DarioHealth (NSDQ:DRIO) said today that authorities in Australia approved the version of its blood glucose monitoring system that fits with the Lightning connector on Apple’s iPhone 7, 8 and X smartphones. Users in Australia will be able to buy the Lightning-enabled Dario device by Jan. 2018, the Israel-based company reported. Get the full story at our sister […]
When DarioHealth (NSDQ:DRIO) CEO Erez Raphael looks at the medical device world, he sees solutions that were designed by healthcare professionals and doctors – and this presents a stark contrast with the consumer device industry, he pointed out. “We have seen there are a lot of cases, most of the cases in the industry, where the […]
DarioHealth (NSDQ:DRIO) said today that it won CE Mark approval for the version of its Dario blood glucose monitoring system that fits with the Lightning connector on Apple’s iPhone 7 and iPhone 8 smart phones. With this regulatory win, DarioHealth’s smart glucose meter can be used with a 3.5 mm headphone jack or Lightning connector, the […]
DarioHealth (NSDQ:DRIO) said today that it launched its smart diabetes platform in Germany – the ninth country in which the Israel-based company’s technology is commercially available. DarioHealth’s platform includes a blood glucose monitoring system, which connects via a headphone jack to a mobile device. Get the full story at our sister site, Drug Delivery Business News.
Digital health company DarioHealth (NSDQ:DRIO) said today that it closed a $5 million private placement with new and existing investors for shares of the company’s common stock and shares of the company’s Series B convertible preferred stock. The Israel-based company said current shareholders accounted for 58% of the securities sold in the offerings. Get the full story […]
DarioHealth (OTCQB:DRIO) said today it inked a number of private placement offerings totaling $4.3 million in aggregate through the issuance of common stock and Series B convertible preferred stock. The Israel-based company said that current shareholders would account for 54% of the securities to be sold in the offerings, in which the company will issue 483,333 shares […]
DarioHealth (OTCQB:DRIO) said yesterday it won FDA 510(k) approval for its Dario diabetes management application on certain Google (NSDQ:GOOG) Android devices. The approval expands the Israel-based company’s availability from exclusively Apple (NSDQ:AAPL) iOS products, which it has had clearance on since winning FDA clearance for its Dario blood glucose monitoring system in December 2015. DarioHealth said the […]
LabStyle Innovations Corp. (OTCQB:DRIO) said today it is rebranding, shifting its corporate moniker to DarioHealth Corp. The Boston-based company said the new name reflects the “company’s growth and development in the digital health and mHealth space,” and added that it will continue to trade on Nasdaq under the ticker “DRIO.” “The healthcare world is changing, and we believe […]